GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...
Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), says the company is prioritising the United States for product launches and investment, ...
TipRanks on MSN
GSK executives acquire shares under reward plan
An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has announced the acquisition of ordinary shares by several key executives ...
The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...
In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...
This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous drug ...
A significant study suggests that the shingles vaccine, particularly Merck's Zostavax, can lower dementia-related mortality ...
A partnership between a large British drugmaker and a startup that discovers drugs using artificial intelligence has borne fruit. Oxford, UK-based Exscientia said Wednesday that it had delivered the ...
TRENTON, N.J. (AP) -- British drugmaker GlaxoSmithKline will pay $3 billion in fines — the largest health care fraud settlement in U.S. history — for criminal and civil violations involving 10 drugs ...
CARLISLE - GlaxoSmithKline, one of the world’s largest pharmaceutical companies, confirmed Monday that it will close a manufacturing facility in Carlisle next year. Production in Carlisle will end by ...
According to news reports, in April 2021, activist investment firm Elliott Management Corp. acquired a large stake in GSK to put pressure on Chief Executive Officer (CEO), Emma Walmsley, to accelerate ...
Five former GSK employees deported from China. BEIJING— -- China has fined the British pharmaceuticals giant GlaxoSmithKline (GSK) $488.8 million (3 billion Yuan) for a "massive bribery network" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results